Clinical trial · Interventional
HPV Self-Sampling for Cervical Cancer Screening Among Transgender Men and Transmasculine Individuals
NCT03222817CI-TRIAL-00038442completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The proposed study will examine the implementation of a Human Papillomavirus (HPV) self-sampling intervention for unscreened and under-screened transgender men and transmasculine individuals living in South Florida. The study will enroll participants to receive this cervical cancer screening intervention in community venues. The purpose of this study is to pilot the self-sampler for feasibility and acceptability within this underserved population.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cervical Cancer Screening | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| HPV self-sampling | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- HPV Self-sampling
- description
- All participants will receive HPV self-sampling. HPV self-sampling allows an individual to screen themselves for cervical cancer in private, using a device that is similar to a tampon.
- interventionNames
- Behavioral: HPV self-sampling
Primary outcomes (1)
- measure
- Acceptability of HPV self-sampling Questionnaire
- timeFrame
- This questionnaire will be administered immediately after participants self-sample
- description
- This questionnaire, designed with substantial input from community partners, will gauge how acceptable the participants find HPV self-sampling through both closed and open-ended questions regarding ease of use, preference of self-sampler vs. physician-collected Pap smear, as well as open-ended inquiries regarding the self-sampling process.
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 25 Years
- Maximum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria: * Self-identify as transgender male or as transmasculine * Assigned female sex at birth * English speaking * ages 25-65 years * report not having had a pap smear in the last three years * if age 30 and over, report not having a Pap smear/HPV co-test in the past 5 years Exclusion Criteria: * • Those who report having had a hysterectomy * Those who report having history of cervical cancer * Adults unable to consent * Those who are pregnant * Prisoners
References
Publications (0)
Data not yet available
No reference posted for this study.